KRYS Krystal Biotech, Inc.
Price Chart
Executive Summary
President and CEO Krishnan Krish S and President of R&D Krishnan Suma each sold 320 shares of Krystal Biotech on June 4, 2026, for a combined $192K. The sales are tiny relative to the $9.1B market cap (0.002%), are identical in size and price, and likely reflect routine tax-related or 10b5-1 plan activity rather than a bearish signal. The cluster is not material enough to change the fundamental outlook.
Key Financial Metrics
Actionable Insight
The insider sales are too small to warrant a trading response. Monitor for any larger open-market sales or changes in 10b5-1 plans. The company's strong analyst consensus (89% bullish) and positive historical performance on prior reports suggest the fundamental story remains intact.
Key Facts
- Two insiders (CEO and President of R&D) each sold 320 shares at $300.75 on June 4, 2026.
- Total sale value is $192K, representing ~0.002% of the $9.1B market cap.
- Identical share counts and price suggest coordinated or plan-driven sales, not opportunistic selling.
- No open-market purchases in the cluster; no other material insider activity in the prior 30 days.
Financial Impact
Trivial — $192K in sales vs. $9.1B market cap (0.002%). No material financial impact.
Risk Factors
- Insider sales could increase if management is diversifying ahead of a catalyst event (e.g., pipeline readout).
- No purchases in the cluster — lack of insider buying may indicate management sees limited near-term upside.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KRYS-1780699267801 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 16, 2026
5d ago
|
ANALYST-UPGRADE
| $249.39 $291.93 | ▲ +17.06% | ▲ +16.77% | $348.06 (+39.56%) |
|
Jun 5, 2026
15d ago
|
Insider Cluster
| $301.76 $324.75 | ▲ +7.62% | ▲ +5.51% | $348.06 (+15.34%) |
|
May 16, 2026
5w ago
|
ANALYST-UPGRADE
| $249.39 $291.93 | ▲ +17.06% | ▲ +16.79% | $348.06 (+39.56%) |
|
May 4, 2026
6w ago
|
Press Release
| $286.95 $312.88 | ▲ +9.04% | ▲ +6.10% | $348.06 (+21.30%) |
|
Apr 21, 2026
8w ago
|
Press Release
| $272.66 $269.27 | ▼ −1.24% | ▼ −2.33% | $348.06 (+27.65%) |
|
Apr 16, 2026
9w ago
|
ANALYST-UPGRADE
| $274.21 $272.52 | ▼ −0.62% | ▼ −1.17% | $348.06 (+26.93%) |
|
Apr 3, 2026
11w ago
|
DEFA14A
| $261.80 $267.41 | ▲ +2.14% | ▼ −1.99% | $348.06 (+32.95%) |
|
Feb 27, 2026
16w ago
|
Insider Cluster
| $275.64 $253.69 | ▼ −7.96% | ▼ −5.98% | $348.06 (+26.27%) |
|
Feb 27, 2026
16w ago
|
Insider Cluster
| $275.64 $253.69 | ▼ −7.96% | ▼ −5.98% | $348.06 (+26.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access